Haeggquist & Eck, LLP, a leading shareholder rights litigation firm, is investigating whether certain directors and officers of RE/MAX Holdings, Inc. (“REMAX” or the “Company”) (NYSE: RMAX) breached their fiduciary duties to the Company and its shareholders. If you are a REMAX Healthcare shareholder, you are encouraged to contact Haeggquist & Eck for additional information.

RE/MAX is a franchisor of real estate and mortgage brokerage services in the United States, Canada, and globally.

On November 2, 2017, RE/MAX revealed that its Board of Directors appointed a special committee “to investigate allegations concerning actions of certain members of the Company’s senior management including an allegation of a previously undisclosed loan of personal funds from David L. Liniger, the Company’s Co-Chief Executive Officer and Chairman, to Adam M. Contos, the Company’s Co-Chief Executive Officer, and allegations of wrongdoing in employment practices and conduct.”

Accordingly, the Company announced that it would delay its third quarter 2017 earnings release and conference call pending further work in connection with this internal investigation. On this news, RE/MAX stock dropped $10.30, or 15.4%, to close at $56.40 on November 3, 2017

What You Can Do

If you are a REMAX shareholder, you may have legal claims against REMAX’s directors and officers. If you wish to discuss this investigation, or have questions about this notice or your legal rights, please call attorney Amber Eck at 619-342-8000 or e-mail her at ambere@haelaw.com. There is no cost or obligation to you.

Haeggquist & Eck, LLP is a nationally recognized leader in shareholder rights law. The firm represents individual investors in shareholder derivative lawsuits, and members of the firm have helped shareholders recover more than $1 billion of value for themselves and the companies in which they have invested.

This release constitutes attorney advertising. Past results do not guarantee a similar outcome.